Next Science Ltd (AU:NXS) has released an update.
Next Science Limited has published its 2023 Annual Report, adhering to ASX listing requirements, and has simultaneously announced the upcoming 2024 Annual General Meeting. The company, known for pioneering the XBIO™ technology aimed at combating biofilm-based infections, continues to hold all patents related to this innovative medical approach. Investors and other interested parties can access these documents and obtain more details on the company’s website.
For further insights into AU:NXS stock, check out TipRanks’ Stock Analysis page.
